SDGR: רווח למניה בשנים עשר החודשים האחרונים Schrodinger Inc

Schrodinger, Inc. (SDGR) possesses significant pricing power, leveraging quantum physics for ultra-precise drug modeling. The company's cloud ecosystem accelerates molecule discovery, establishing itself as a key hub for biochemistry. The annual net income per share trend illustrates financial stability, where the value -0.79 represents the most recent figure. Business stability is reinforced by a unique staff of scientists and AI architects with minimal employee turnover.

Net income per share over 12 months reflects the actual efficiency of capital generation per security, excluding the impact of changes in the equity structure. By analyzing the trailing 12-month net income per share, an investor assesses the business resilience of Schrodinger, Inc. (SDGR) against biotech sector R&D expenditure volatility and the uncertainty surrounding the monetization timelines of innovative software developments.